DAVID PECKHAM: Open Payments
NPI 1548411796 · QUINCY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,612 in 254 payments from 20 companies in 2025. Trend: 2023 $9,818 · 2024 $24,753 · 2025 $19,612
Speaker / faculty: $14,400Food & beverage: $5,091Education: $70Travel & lodging: $52
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 42 | $15,391 |
| ABBVIE INC. | 81 | $1,007 |
| UCB, Inc. | 16 | $502 |
| E.R. Squibb & Sons, L.L.C. | 15 | $367 |
| Novartis Pharmaceuticals Corporation | 17 | $366 |
| LEO Pharma Inc. | 14 | $350 |
| Incyte Corporation | 9 | $228 |
| Regeneron Healthcare Solutions, Inc. | 10 | $219 |
| Botanix SB Inc | 7 | $204 |
| Amgen Inc. | 11 | $192 |
Products named: TREMFYA, SKYRIZI, Bimzelx, Sotyktu, RINVOQ, DUPIXENT, ADBRY, OPZELURA.
Industry payments across MA — which companies pay providers there.
